Read the December 31st LEAD Coalition Newsletter below.
Category: Uncategorized
LEAD Coalition November 25th, 2024 News
Read the November 25th LEAD Coalition Newsletter below.
LEAD Coalition October 30th, 2024 News
Read the October 30th LEAD Coalition Newsletter below.
LEAD Coalition September 30th, 2024 News
Read the September 30th LEAD Coalition Newsletter below.
LEAD Coalition August 28th, 2024 News
Read the August 28th LEAD Coalition Newsletter below.
LEAD Coalition submits comments on Congressional framework for reforming the NIH
The LEAD Coalition has submitted a letter providing input on House Energy and Commerce Committee Chair Cathy McMorris Rodgers’ “Reforming the National Institutes of Health Framework for Discussion.” The LEAD Coalition letter encourages a congressional process that ensures Alzheimer’s disease and related disorders research continues to be addressed collaboratively across NIH with a life-course, person-centered […]
LEAD Coalition July 29th, 2024 News
Read the July 29th LEAD Coalition Newsletter below.
LEAD Coalition June 27th, 2024 News
Read the June 27th LEAD Coalition Newsletter below.
LEAD Coalition submits public comments for FDA review of donanemab
Today, 265 LEAD Coalition member organizations and allies sent a joint public comment letter to the U.S. Food and Drug Administration (FDA) regarding its review of the supplemental biologics license application for donanemab (BLA 761248) for the treatment of mild cognitive impairment and early dementia due to Alzheimer’s disease. The letter expresses full confidence in […]
LEAD Coalition May 29th, 2024 News
Read the May 29th LEAD Coalition Newsletter below.